miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma

MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma

(2017) Lipin Liu et al.   Molecular Cancer

LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation

(2017) C Zhou et al.   ONCOGENE

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity

(2016) Toshiro Moroishi et al.   CELL

Mechanisms of Hippo pathway regulation

(2016) Zhipeng Meng et al.   GENES & DEVELOPMENT

Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma

(2016) Junyong Zhang et al.   Scientific Reports

DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR

(2016) Goran Micevic et al.   Cell Reports

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

(2015) Fa-Xing Yu et al.   CELL

Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches

(2015) Tim F Greten et al.   GUT

Effects of the Hippo Signaling Pathway in Human Gastric Cancer

(2014) Guang-Xi Zhou et al.   Asian Pacific Journal of Cancer Prevention

Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer

(2014) Xiaojing Yang et al.   CANCER CELL

Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions

(2014) Hao Wu et al.   CELL

miRNA and Methylation: A Multifaceted Liaison

(2014) Ravindresh Chhabra   CHEMBIOCHEM

Demethylating Drugs as Novel Analgesics for Cancer Pain

(2014) C. T. Viet et al.   CLINICAL CANCER RESEARCH

Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome

(2014) Sonya Parpart et al.   HEPATOLOGY

Methylation-associated inactivation of LATS1 and its effect on demethylation or overexpression on YAP and cell biological function in human renal cell carcinoma

(2014) KE-HONG CHEN et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia

(2014) C Niederwieser et al.   LEUKEMIA

Therapeutic targeting of microRNAs: current status and future challenges

(2014) Zhonghan Li et al.   NATURE REVIEWS DRUG DISCOVERY

Identification and consequences of miRNA–target interactions — beyond repression of gene expression

(2014) Jean Hausser et al.   NATURE REVIEWS GENETICS

DNA Methyltransferases: A Novel Target for Prevention and Therapy

(2014) Dharmalingam Subramaniam et al.   Frontiers in Oncology

miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases

(2013) Sumiyo Morita et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

miRNA-29c Suppresses Lung Cancer Cell Adhesion to Extracellular Matrix and Metastasis by Targeting Integrin β1 and Matrix Metalloproteinase2 (MMP2)

(2013) Heyong Wang et al.   PLoS One

Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis

(2012) B. Zhao et al.   GENES & DEVELOPMENT

Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice

(2012) Miki Nishio et al.   JOURNAL OF CLINICAL INVESTIGATION

Decreased expression of LATS1 is correlated with the progression and prognosis of glioma

(2012) Tianhai Ji et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Biology of Hepatocellular Carcinoma

(2008) Roberta W. C. Pang et al.   ANNALS OF SURGICAL ONCOLOGY

Separation of miRNA and its methylation products by capillary electrophoresis

(2008) Ni Li et al.   JOURNAL OF CHROMATOGRAPHY A

Gene Regulation by Transcription Factors and MicroRNAs

(2008) O. Hobert   SCIENCE